Results
14
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
14 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
STMN | CHF 125.10 | -1.8% | -10.6% | CHF 19.9b | CHF 132.05 | PE69.3x | E20.1% | 0.7% | Healthcare | ||
VACN | CHF 348.90 | 0.5% | -17.4% | CHF 10.5b | CHF 375.52 | PE52.3x | E20.0% | 1.8% | Capital Goods | ||
SDZ | CHF 44.56 | 5.1% | 61.2% | CHF 19.5b | CHF 44.39 | PS2.1x | E29.5% | 1.0% | Pharmaceuticals & Biotech | ||
GALD | CHF 117.10 | 3.4% | n/a | CHF 27.8b | CHF 104.26 | PS7.1x | E36.6% | n/a | Pharmaceuticals & Biotech | ||
LONN | CHF 605.20 | 1.3% | 35.5% | CHF 43.7b | CHF 657.95 | PE68.7x | E21.1% | 0.7% | Pharmaceuticals & Biotech | ||
SGSN | CHF 91.16 | 4.2% | 10.3% | CHF 17.0b | CHF 92.62 | PE31x | E12.1% | 3.5% | Commercial Services | ||
PGHN | CHF 1,406.50 | 2.0% | 15.6% | CHF 36.7b | CHF 1,374.07 | PE38.2x | E14.7% | 2.8% | Diversified Financials | ||
SREN | CHF 142.00 | 2.3% | 41.4% | CHF 41.4b | CHF 140.87 | PE15.5x | E12.5% | 4.4% | Insurance | ||
UBSG | CHF 30.31 | -4.7% | 23.7% | CHF 96.2b | CHF 31.44 | PE20.8x | E23.3% | 2.7% | Diversified Financials | ||
SOON | CHF 304.90 | -3.5% | 7.1% | CHF 18.2b | CHF 301.17 | PE32.2x | E10.3% | 1.4% | Healthcare | ||
ROG | CHF 290.60 | 1.7% | 27.7% | CHF 233.2b | CHF 307.34 | PE27.9x | E14.3% | 3.3% | Pharmaceuticals & Biotech | ||
CFR New | CHF 175.90 | 0.09% | 30.2% | CHF 103.8b | CHF 169.02 | PE32.6x | E12.4% | 1.5% | Consumer Durables | ||
GIVN | CHF 3,828.00 | -2.5% | 6.1% | CHF 35.3b | CHF 4,149.20 | PE32.4x | E6.4% | 1.8% | Materials | ||
ABBN | CHF 50.08 | 2.1% | 30.3% | CHF 92.0b | CHF 49.37 | PE25.6x | E8.6% | 1.8% | Capital Goods |